![Paul Fry](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul Fry
Director of Finance/CFO at
OXFORD INSTRUMENTS PLC
Net worth: 101 622 $ as of 30/09/2026
Profile
Mr. Paul A. Fry is a Chief Financial Officer & Director at Oxford Instruments Plc and a Member at The Chartered Institute of Management Accountants.
He is on the Board of Directors at Oxford Instruments Plc, Vectura Delivery Devices Ltd., Vectura Group Services Ltd. and Vectura Ltd. Mr. Fry was previously employed as an Independent Non-Executive Director by Avacta Group Plc, a Chief Financial Officer & Executive Director by Vectura Group Ltd., a Chief Financial Officer by Immunocore Holdings Plc, a Chief Financial Officer by Argenta Syndicate Management Ltd., a Chief Financial Officer by GlaxoSmithKline SpA, a Chief Financial Officer by Immunocore Ltd., and a Director-Global Finance Operations by Vodafone Group Plc.
He also served on the board at Quadrant Healthcare Ltd. He received his undergraduate degree from the University of Oxford.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 10/09/2026 | 2,533 ( 0% ) | 101 622 $ | 30/09/2026 |
Paul Fry active positions
| Companies | Position | Start |
|---|---|---|
| OXFORD INSTRUMENTS PLC | Director of Finance/CFO | 01/04/2025 |
Vectura Delivery Devices Ltd.
 Vectura Delivery Devices Ltd. BiotechnologyHealth Technology Engages in research, development and commercialisation of pharmaceutical products | Director/Board Member | 30/06/2019 |
Vectura Group Services Ltd.
 Vectura Group Services Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business support services | Director/Board Member | 30/06/2019 |
Vectura Ltd.
 Vectura Ltd. Medical SpecialtiesHealth Technology Manufactures medical equipment | Director/Board Member | 30/06/2019 |
The Chartered Institute of Management Accountants
 The Chartered Institute of Management Accountants Other Consumer ServicesConsumer Services College/University | Corporate Officer/Principal | - |
Former positions of Paul Fry
| Companies | Position | End |
|---|---|---|
| AVACTA GROUP PLC | Director/Board Member | 30/09/2026 |
| VECTURA GROUP | Chief Executive Officer | 07/11/2019 |
Argenta Syndicate Management Ltd.
 Argenta Syndicate Management Ltd. Multi-Line InsuranceFinance Provides non-life insurance and reinsurance services | Director of Finance/CFO | - |
Immunocore Ltd.
 Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes transformative medicines for cancer, infection and autoimmune disease | Director of Finance/CFO | - |
| ░░░░░░░░ ░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Education of Paul Fry
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
80
1st degree connections
14
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 14 |
|---|---|
Vodafone Group Plc
 Vodafone Group Plc Wireless TelecommunicationsCommunications Provides mobile and fixed telecommunications services | Communications |
Vectura Group Ltd.
 Vectura Group Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures inhalation drugs and medical devices | Health Technology |
The Chartered Institute of Management Accountants
The Chartered Institute of Management Accountants Other Consumer ServicesConsumer Services College/University | Consumer Services |
Oxford Instruments Plc
 Oxford Instruments Plc Electronic Equipment/InstrumentsElectronic Technology Operates as a holding company whose subsidiaries provides products and solutions that enable fabrication & characterization of materials and devices | Electronic Technology |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline SpA
 GlaxoSmithKline SpA Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceutical products, vaccines and health products | Health Technology |
Avacta Group Plc
 Avacta Group Plc Miscellaneous Commercial ServicesCommercial Services Engages in the business of healthcare technology and consumables | Commercial Services |
Quadrant Healthcare Ltd.
 Quadrant Healthcare Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Argenta Syndicate Management Ltd.
Argenta Syndicate Management Ltd. Multi-Line InsuranceFinance Provides non-life insurance and reinsurance services | Finance |
Vectura Ltd.
Vectura Ltd. Medical SpecialtiesHealth Technology Manufactures medical equipment | Health Technology |
Vectura Group Services Ltd.
Vectura Group Services Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business support services | Commercial Services |
Vectura Delivery Devices Ltd.
Vectura Delivery Devices Ltd. BiotechnologyHealth Technology Engages in research, development and commercialisation of pharmaceutical products | Health Technology |
Immunocore Holdings Plc
 Immunocore Holdings Plc BiotechnologyHealth Technology Operates as a biotechnology company which develops immunotherapies | Health Technology |
Immunocore Ltd.
Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes transformative medicines for cancer, infection and autoimmune disease | Health Technology |
- Stock Market
- Insiders
- Paul Fry
